Gold Nanoparticles for Neurodegenerative Disease: Cutting-Edge Innovation
Product Overview
Discover the next frontier in neurodegenerative disease treatment with our specially engineered gold nanoparticles (AuNPs). These nanoparticles represent a significant breakthrough in medical nanotechnology research, offering a novel approach to tackling complex neurodegenerative conditions such as Alzheimer's, Parkinson's, and multiple sclerosis studies in lab specimens.
For more information: Gold Nanoparticles for Neurodegenerative Disease Info
Key Features
-
Targeted Drug Delivery: Our gold nanoparticles are designed for precision targeting, delivering therapeutic agents directly to affected brain regions. This targeted approach maximizes the efficacy of the treatment while minimizing systemic side effects.
-
Neuroprotective Properties: The unique surface chemistry of our AuNPs promotes neuroprotection by reducing oxidative stress and inflammation, two key factors in the progression of neurodegenerative diseases.
-
Enhanced Blood-Brain Barrier Penetration: These nanoparticles are engineered to efficiently cross the blood-brain barrier, ensuring that therapeutic agents reach the central nervous system, where they are most needed.
-
Biocompatibility and Safety: Our gold nanoparticles are coated with biocompatible ligands that minimize immune responses and ensure safety in long-term applications.
-
Customizable Surface Functionalization: The surface of our gold nanoparticles can be functionalized with various ligands, peptides, or antibodies, allowing for customization to target specific disease markers or enhance therapeutic efficacy.
Applications
-
Alzheimer’s Disease: The gold nanoparticles are being tested for their ability to reduce amyloid plaques and tau tangles, which are hallmarks of Alzheimer's disease. Early results from the trials show promise in slowing disease progression.
-
Parkinson’s Disease: In Parkinson's, these nanoparticles are being explored for their potential to deliver neuroprotective agents directly to the substantia nigra, the brain region most affected by the disease.
-
Multiple Sclerosis (MS): For MS, our gold nanoparticles are under investigation for their role in reversing demyelination and protecting nerve fibers from further damage.
Why Choose Our Gold Nanoparticles?
Choosing our gold nanoparticles means investing in the future of neurodegenerative disease research. With a focus on innovation, safety, and efficacy, we are committed to providing solutions that can change the course of these debilitating conditions in lab studies.
- Proven Research: Backed by years of research and multiple publications in peer-reviewed journals, our gold nanoparticles are at the forefront of Research medical nanotechnology.
- Commitment to Quality: Manufactured under stringent quality control processes, our nanoparticles meet the highest standards for research use.
Product Details
Please note these products are non toxic and are for in vivo Research use in Laboratory animals. Administration route is through oral or tail vein injection. These gold nanoparticles are 1.8nm in diameter, with a 100Da PEG capping to promote bio cloaking and blood brain barrier (BBB) transport, but allow for oxidative interaction. Typical studies involve daily intake of 0.025mg product per 100g body weight for 7-15 days. Consumption of this product will lead to the systemic absorption of gold nanoparticles, followed by their eventual excretion through the urinary tract. Upon consumption, the nanoparticles are absorbed into the bloodstream, circulate throughout the body, passing the BBB and are ultimately filtered by the kidneys. The renal system then facilitates the excretion of these nanoparticles in the urine, completing the elimination process. For Research Use Only.